- Home
- NAMS vs MQ Comparison
NAMS vs MQ Comparison
Compare NAMS & MQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAMS
- MQ
- Stock Information
- Founded
- NAMS 2019
- MQ 2010
- Country
- NAMS Netherlands
- MQ United States
- Employees
- NAMS N/A
- MQ N/A
- Industry
- NAMS Biotechnology: Pharmaceutical Preparations
- MQ Computer Software: Prepackaged Software
- Sector
- NAMS Health Care
- MQ Technology
- Exchange
- NAMS Nasdaq
- MQ Nasdaq
- Market Cap
- NAMS 2.2B
- MQ 1.9B
- IPO Year
- NAMS N/A
- MQ 2021
- Fundamental
- Price
- NAMS $18.11
- MQ $5.38
- Analyst Decision
- NAMS Strong Buy
- MQ Hold
- Analyst Count
- NAMS 6
- MQ 13
- Target Price
- NAMS $42.83
- MQ $4.95
- AVG Volume (30 Days)
- NAMS 694.5K
- MQ 10.3M
- Earning Date
- NAMS 05-08-2025
- MQ 05-07-2025
- Dividend Yield
- NAMS N/A
- MQ N/A
- EPS Growth
- NAMS N/A
- MQ N/A
- EPS
- NAMS N/A
- MQ 0.11
- Revenue
- NAMS $47,140,000.00
- MQ $528,100,000.00
- Revenue This Year
- NAMS N/A
- MQ $19.36
- Revenue Next Year
- NAMS N/A
- MQ $22.24
- P/E Ratio
- NAMS N/A
- MQ $50.26
- Revenue Growth
- NAMS 586.97
- MQ N/A
- 52 Week Low
- NAMS $14.06
- MQ $3.37
- 52 Week High
- NAMS $27.29
- MQ $6.00
- Technical
- Relative Strength Index (RSI)
- NAMS 47.80
- MQ 75.61
- Support Level
- NAMS $16.79
- MQ $5.01
- Resistance Level
- NAMS $19.58
- MQ $5.33
- Average True Range (ATR)
- NAMS 0.94
- MQ 0.17
- MACD
- NAMS -0.12
- MQ 0.03
- Stochastic Oscillator
- NAMS 47.07
- MQ 96.61
About NAMS NewAmsterdam Pharma Company N.V.
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.
About MQ Marqeta Inc.
Headquartered in Oakland, California, and founded in 2010, Marqeta provides its clients with a card-issuing platform that offers the infrastructure and tools necessary to offer digital, physical, and tokenized payment options without the need for a traditional bank. The company's open APIs are designed to allow third parties like DoorDash, Klarna, and Block to rapidly develop and deploy innovative card-based products and payment services without the need to develop the underlying technology. The company generates revenue primarily through processing and ATM fees for cards issued on its platform.